Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by CancerSlayer

V.TLT

RE:Determining a Company’s Value - Old School

Gorf79 wrote: Fred, since you didn’t ask I’ll provide it free of charge...

April 23, 2022

V.TLT

RE:U.S. funding 1.6B$ for Novavax's COVID-19

ScienceFirst wrote: Examples of canadian-made Novavax vaccine that shines...

April 19, 2022

V.TLT

RE:RE:Theralase Covid Vaccine with 99.99% Kill Rate!!!

CancerSlayer wrote: Infinity wrote: I understand that animal test...

April 19, 2022

V.TLT

RE:Theralase Covid Vaccine with 99.99% Kill Rate!!!

Infinity wrote: I understand that animal test studies are in progress with...

April 19, 2022

V.TLT

RE:RE:One more look at the new 90 day optimized data

  comorbities = comorbidities.  My iPad must have thought there...

April 18, 2022

V.TLT

RE:One more look at the new 90 day optimized data

Eoganacht wrote: I changed the percentages to patient counts for the recent...

April 18, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin

patience69 wrote: Fred No need to feel alone on the lung cancer questions. I...

April 17, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin

fredgoodwinson wrote: No intention to impugn fellow posters OM many if not...

April 17, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

Gooseybear wrote: Having received 20 BCG treatments, cancer was reoccurring...

April 15, 2022

V.TLT

RE:RE:RE:RE:RE:RE:Briacell dropping 30% after FASTTRACK

enriquesuave wrote: They clearly stated very positive Evaluable CR rates...

April 15, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

enriquesuave wrote: If a patient is lying on his back, I suspect that the...

April 13, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

The updated protocol/bladder volume calculation (although not perfect) should...

April 13, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

tdon1229 wrote: CancerSlayer wrote:   2b7f6fab...

April 13, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

2b7f6fab wrote: The kil rate in vitro seems to be 100%.   Why...

April 13, 2022

V.TLT

RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

Rumpl3StiltSkin wrote: stocksnbonds458 wrote: Perhaps a silly question...

April 13, 2022

V.TLT

RE:RE:RE:RE:RE:RE:Signing up new trial patients

Eoganacht wrote: Hopefully there will be a way to get to TLD1433 pdt as a...

April 9, 2022

V.TLT

Just saw Dawg’s data tracker

Updated data interpretation noted....thanks. Just noted what appears to be a...

April 6, 2022

V.TLT

RE:RE:RE:RE:Heads Should Roll

CancerSlayer wrote: enriquesuave wrote: "Conclusion: Study II...

April 6, 2022

V.TLT

RE:RE:RE:Heads Should Roll

enriquesuave wrote: "Conclusion: Study II has delivered significant...

April 6, 2022

V.TLT

RE:RE:Today

I must be the only one working? : ).  Just got off work & haven'...

April 5, 2022

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Nextech3D.ai

Nextech3D.ai C.NTAR

Nextech3D.ai is a diversified technology company that leverages proprietary artificial intelligence (AI) to create 3D models ... view more »